今开:3.69 | 昨收:3.7 |
最高:3.87 | 最低:3.62 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.15567194E8 |
Relmada Therapeutics(RLMD)02-14 21:55
$Relmada治疗(RLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-000937 Act: 34 Size: 103 KB 网页链接查看全文
Relmada Therapeutics(RLMD)03-20 04:15
$Relmada治疗(RLMD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-024022 Act: 34 Size: 340 KB 网页链接查看全文
Relmada Therapeutics(RLMD)03-20 04:15
$Relmada治疗(RLMD)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-24-024013 Act: 34 Size: 4 MB 网页链接查看全文
Relmada Therapeutics(RLMD)02-14 06:25
$Relmada治疗(RLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-021823 Act: 34 Size: 13 KB 网页链接查看全文
Relmada Therapeutics(RLMD)02-01 07:35
$Relmada治疗(RLMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-008559 Size: 8 KB 网页链接查看全文
Relmada Therapeutics(RLMD)02-01 07:35
$Relmada治疗(RLMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-008560 Size: 8 KB 网页链接查看全文
Relmada Therapeutics(RLMD)02-01 07:35
$Relmada治疗(RLMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-008557 Size: 8 KB 网页链接查看全文
Relmada Therapeutics(RLMD)02-14 20:55
$Relmada治疗(RLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001574 Act: 34 Size: 61 KB 网页链接查看全文
Relmada Therapeutics(RLMD)03-07 05:25
$Relmada治疗(RLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-060735 Act: 34 Size: 65 KB 网页链接查看全文
Relmada Therapeutics(RLMD)02-21 07:05
$Relmada治疗(RLMD)$ 144 Report of proposed sale of securities Accession Number: 0001972362-24-000160 Act: 33 Size: 4 KB 网页链接查看全文
$Relmada Therapeutics(RLMD)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-24-031609 Act: 34 Size: 3 MB 网页链接
$Relmada Therapeutics(RLMD)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-24-031600 Act: 34 Size: 4 MB 网页链接
$Relmada治疗(RLMD)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-24-024013 Act: 34 Size: 4 MB 网页链接
$Relmada治疗(RLMD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-024022 Act: 34 Size: 340 KB 网页链接
$Relmada治疗(RLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-060735 Act: 34 Size: 65 KB 网页链接
$Relmada治疗(RLMD)$ 144 Report of proposed sale of securities Accession Number: 0001972362-24-000160 Act: 33 Size: 4 KB 网页链接
$Relmada治疗(RLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-000937 Act: 34 Size: 103 KB 网页链接
$Relmada治疗(RLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001574 Act: 34 Size: 61 KB 网页链接
$Relmada治疗(RLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-021823 Act: 34 Size: 13 KB 网页链接
$Relmada治疗(RLMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-008560 Size: 8 KB 网页链接